Ask AI
Bill114th CongressFiled Mar 19, 2015Health
H.R. 1462

Protecting Our Infants Act of 2015

Bill journey · stage 1 of 5

Just introduced

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house without amendment (Sep 8, 2015)

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Protecting Our Infants Act of 2015

(Sec. 3) This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
  • an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
  • recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.

(Sec. 4) The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.

(Sec. 5) The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.

What just happenedJul 14, 2016

Indefinitely postponed by Senate by Unanimous Consent. (consideration: CR S5195)

Who’s behind it

Rep. Clark, Katherine M. [D-MA-5](D-MA)Sponsor
99 cosponsors58 D41 R
Read on Congress.gov
99cosponsors1committees19actions1related bills11subjects
  1. Jul 14, 2016Floor

    Indefinitely postponed by Senate by Unanimous Consent. (consideration: CR S5195)

  2. Sep 9, 2015IntroReferral

    Received in the Senate.

  3. Sep 8, 2015FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  4. Sep 8, 2015FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5798-5799)

  5. Sep 8, 2015Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5798-5799)

  6. Sep 8, 2015FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 1462.

  7. Sep 8, 2015FloorH30000

    Considered under suspension of the rules. (consideration: CR H5798-5801)

  8. Sep 8, 2015FloorH30300

    Mr. Guthrie moved to suspend the rules and pass the bill.

  9. Sep 8, 2015CalendarsH12410

    Placed on the Union Calendar, Calendar No. 185.

  10. Sep 8, 2015CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 114-244.

    Energy and Commerce Committee
  11. Sep 8, 2015Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 114-244.

    Energy and Commerce Committee
  12. Jul 29, 2015Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  13. Jul 29, 2015Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  14. Jul 23, 2015Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  15. Jul 23, 2015Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  16. Mar 20, 2015Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  17. Mar 19, 2015IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  18. Mar 19, 2015IntroReferralIntro-H

    Introduced in House

  19. Mar 19, 2015IntroReferral1000

    Introduced in House

Passed House without amendmentSep 8, 201581

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Protecting Our Infants Act of 2015

(Sec. 3) This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
  • an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
  • recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.

(Sec. 4) The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.

(Sec. 5) The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.
Introduced in HouseMar 19, 2015

Protecting Our Infants Act of 2015

This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
  • an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
  • recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.

The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.

The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.
Protecting Our Infants Act of 2015 — Informed